2016-03-15T00:00:00.000-04:00
Morgan Stanley analyst,-0.486515
investors,0.416978
Buy rating,0.354873
data,0.255868
Leerink analyst Seamus,-0.0639864
price target,-0.06887
Suisse analyst Kennen,0.332849
analyst Bruce Nudell,0.280834
European Patent Office,-0.413397
Jaffray analyst Charles,0.409925
Outperform rating,0.400445
analyst views,-0.470452
stock,0.0356389
Piper Jaffray analyst,0.0748558
Barclays analyst Jonathan,0.323035
Jaffray analyst Joshua,-0.335069
analyst Seamus Fernandez,-0.0639864
analyst coverage,0.701499
research note,0.240332
Overweight rating,0.532926
Outperform ratings,-0.359226
Eli Lilly,-0.0601713
analyst Andrew Berens,-0.486515
Credit Suisse,-0.0391866
shares,-0.0855758
analyst initiations,0.323979
analyst Paul Matteis,-0.566651
JPMorgan analyst Cory,0.40858
company,0.00124353
SAGE Therapeutics,-0.441208
higher price target,0.35934
morning trading,0.281472
target product profile,0.269279
Credit Suisse analyst,0.332849
analyst Charles Duncan,0.409925
analyst Robyn Karnauskas,-0.247372
